3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Obesity
9
Endometrial Neoplasms
5
Prostatic Neoplasms
2
Overweight
2
Diabetes Mellitus
2
Breast Neoplasms
2
Weight Loss
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Opioid-Related Disorders
1
Metabolic Syndrome
1
Lymphoma, Follicular
1
Insulin Resistance
1
Inflammation
1
Hyperplasia
1
Endometrial Hyperplasia
1
Dyslipidemias
1
Colorectal Neoplasms
1
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
27
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
Tirzepatide
×
Clear all
NCT07326111
2026-01-08
PERIODS
University of Bonn
Phase 4
Recruiting
198 enrolled